About 7 results found for searched term "65-29-2" (0.079 seconds)
Cat.No. | Name | Target |
---|---|---|
M2868 | MPI-0479605 | Kinesin |
MPI-0479605 is an ATP competitive and selective inhibitor of mitotic kinase Mps1 with IC50 of 1.8 nM, >40-fold selectivity over other kinases. | ||
M5318 | Zoligratinib | EGFR/HER2 |
CH5183284;Debio 1347 | ||
CH5183284 is a selective and orally available FGFR inhibitor with IC50 of 9.3 nM, 7.6 nM, 22 nM, and 290 nM for FGFR1, FGFR2, FGFR3, and FGFR4, respectively. Phase 1. | ||
M5673 | Gallamine Triethiodide | AChR/AChE |
Gallamine Triethiodide is a cholinergic receptor blocker with an IC50 of 68.0 ± 8.4 μM. | ||
M7085 | OR-486 | Others |
OR-486 is a catechol O-methyltransferase inhibitor. | ||
M9212 | Aramchol | Stearoyl-CoA Desaturase |
Arachidyl amido cholanoic acid; C20-FABAC; Icomidocholic acid | ||
Aramchol is a novel fatty acid bile acid coupling agent with oral activity and an inhibitor of SCD1, which acts by inhibiting SCD1 expression in hepatocytes and hepatic astrocytes, and can be used in studies related to non-alcoholic steatohepatitis (NASH). | ||
M29073 | Valiglurax | GluR |
VU0652957; VU2957 | ||
Valiglurax (VU0652957) is a potent, orally active and selective mGlu4 positive allosteric modulator with EC50 values of 64.6 nM and 197 nM for hmGlu4/Gqi5 and rmGlu4 GIRK, respectively. Valiglurax is a central nervous system (CNS) penetrant. Valiglurax can be used in research of Parkinson's disease. | ||
M30509 | Rachelmycin | Antibiotic |
CC-1065; NSC 298223 | ||
Rachelmycin (CC-1065) is an antitumor antibiotic and a DNA-alkylating agent. Rachelmycin has cytotoxic potency that can be used as a cytotoxin to synthesis ADC. Rachelmycin effectively inhibits DNA synthesis. Rachelmycin can be used for cancer and infection research. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.